John F. Greden
#126,351
Most Influential Person Now
John F. Greden's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is John F. Greden Influential?
(Suggest an Edit or Addition)John F. Greden's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. (1981) (2003)
- Depression in Persons with Autism: Implications for Research and Clinical Care (2002) (600)
- Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. (2005) (593)
- Living with a depressed person. (1987) (513)
- Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. (1989) (429)
- Insomnia, self-medication, and relapse to alcoholism. (2001) (373)
- The Carroll Rating Scale for Depression I. Development, Reliability and Validation (1981) (364)
- Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia. (1989) (346)
- The DST as a predictor of outcome in depression: a meta-analysis. (1993) (330)
- Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. (1983) (304)
- The burden of disease for treatment-resistant depression. (2001) (278)
- Anxiety or caffeinism: a diagnostic dilemma. (1974) (275)
- Impaired lymphocyte function in depressive illness. (1983) (270)
- The burden of recurrent depression: causes, consequences, and future prospects. (2001) (263)
- Positive and negative syndromes in schizophrenia. (1989) (224)
- Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. (1981) (217)
- Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. (1992) (195)
- A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. (1988) (190)
- Anxiety and depression associated with caffeinism among psychiatric inpatients. (1978) (182)
- Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome (1991) (175)
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study. (2019) (162)
- Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. (1984) (157)
- EEG studies of sleep in the diagnosis of depression. (1982) (157)
- Antidepressant withdrawal phenomena. (1984) (154)
- Buddy‐to‐Buddy, a citizen soldier peer support program to counteract stigma, PTSD, depression, and suicide (2010) (149)
- Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. (1980) (148)
- Depression in Children with Autism/Pervasive Developmental Disorders: A Case-Control Family History Study (1998) (140)
- Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. (2002) (139)
- Physical symptoms of depression: unmet needs. (2003) (136)
- Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria. (1980) (133)
- Neuroendocrine evaluation of depression in borderline patients. (1981) (131)
- Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. (2010) (124)
- Depression, Urinary Free Cortisol Excretion and Lymphocyte Function (1986) (111)
- Depression in stroke rehabilitation (1993) (110)
- Life events and depression in children with pervasive developmental disorders (1995) (108)
- Muscarinic cholinergic hyperactivity in schizophrenia relationship to positive and negative symptoms (1991) (108)
- NEUROTRANSMITTER STUDIES OF NEUROENDOCRINE PATHOLOGY IN DEPRESSION (1980) (107)
- Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression. (1980) (105)
- Fluoxetine versus phenelzine in atypical depression (1996) (99)
- Simultaneous panic and depressive disorder: response to antidepressant treatments. (1986) (88)
- Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment. (1981) (86)
- Psychomotor function in affective disorders: an overview of new monitoring techniques. (1981) (86)
- Antidepressant Withdrawal Syndromes: Evidence Supporting the Cholinergic Overdrive Hypothesis (1983) (81)
- Multiple HPA profiles in endogenous depression: Effect of age and sex on cortisol and beta-endorphin (1993) (79)
- Caffeine-withdrawal headache: a clinical profile. (1980) (77)
- Tissue Responses to Addictive Drugs (1978) (75)
- Dissociation between pituitary and adrenal suppression to dexamethasone in depression. (1993) (74)
- Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression (1980) (73)
- Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. (2010) (73)
- Antidepressant withdrawal-induced activation (hypomania and mania): Mechanism and theoretical significance (1984) (73)
- Anxiogenic effects of caffeine on panic and depressed patients. (1988) (69)
- Interference by carbamazepine with the dexamethasone suppression test. (1982) (68)
- Somatic manifestations of caffeinism. (1981) (68)
- Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications (1991) (68)
- Speech pause time: a marker of psychomotor retardation among endogenous depressives. (1981) (66)
- Effect of anticholinergics on positive and negative symptoms in schizophrenia. (1992) (66)
- Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression. (1996) (66)
- Treatment guidelines for depression in pregnancy (2001) (66)
- What happened to lithium? Antidepressant augmentation in clinical settings. (2006) (64)
- Decrease in speech pause times with treatment of endogenous depression. (1980) (64)
- SUICIDE, NEUROENDOCRINE DYSFUNCTION AND CSF 5-HIAA CONCENTRATIONS IN DEPRESSION (1981) (62)
- Antidepressant withdrawal symptoms treated with anticholinergic agents. (1983) (58)
- Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. (1994) (56)
- Anxiety and caffeine consumption in people with anxiety disorders (1985) (55)
- Measurement of depression and negative symptoms in schizophrenia. (1992) (54)
- Antidepressant maintenance medications: when to discontinue and how to stop. (1993) (53)
- Antidepressant withdrawal syndromes: evidence for supersensitivity of cholinergic system as an etiologic factor. (1983) (51)
- Serial dexamethasone suppression tests among rapidly cycling bipolar patients. (1982) (50)
- Agitation-increased electromyogram activity in the corrugator muscle region: a possible explanation of the "Omega sign"? (1985) (49)
- Facial electromyography in depression. Subgroup differences. (1986) (49)
- The Institute of Medicine’s Report on Research Training in Psychiatry Residency: Strategies for Reform—Background, Results, and Follow Up (2004) (48)
- Association between abnormal REM sleep and negative symptoms in schizophrenia (1989) (47)
- Immune function in alcoholism: a controlled study. (1993) (47)
- The dexamethasone suppression test as a diagnostic aid in catatonia. (1979) (46)
- Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: A replication (1993) (45)
- Coffee, Tea and You (1979) (45)
- Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia (1989) (43)
- Treatment of negative schizophrenic symptoms with trihexyphenidyl. (1988) (42)
- β-Endorphin/β-Lipotropin Immunoreactivity in Endogenous Depression: Effect of Dexamethasone (1986) (40)
- Unmet need: what justifies the search for a new antidepressant? (2002) (39)
- NEUROENDOCRINE DISTURBANCES AND THE DIAGNOSIS AND ÆTIOLOGY OF ENDOGENOUS DEPRESSION (1980) (38)
- Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia (1986) (36)
- Suppression of tumor necrosis factor production by alcohol in lipopolysaccharide-stimulated culture. (1994) (36)
- Chronic fatigue syndrome: The need for an integrative approach (1991) (35)
- Postdexamethasone plasma cortisol and β-endorphin levels in depression: Relationship to severity of illness (1987) (34)
- Effects of antidepressant withdrawal on the dexamethasone suppression test (1985) (34)
- Age effects in serial hypothalamic - pituitary - adrenal monitoring (1986) (34)
- Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial. (2019) (33)
- Depressive pseudodementia: a suggested diagnostic profile. (1983) (33)
- Positive and negative symptoms in schizophrenia and the dexamethasone suppression test (1989) (32)
- Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls (1993) (32)
- Dexamethasone suppression test and selection of antidepressant medications. (1981) (32)
- Shortened REM latency PostECT is associated with rapid recurrence of depressive symptomatology (1994) (31)
- Dysthymia characteristics of heavy alcohol use in depressed adolescents (1993) (31)
- Caffeinism associated with greater use of other psychotropic agents. (1981) (29)
- Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. (1988) (29)
- Lymphocyte numbers in endogenous depression (1987) (29)
- Central Serotonergic Effects of m-Chlorophenylpiperazine (mCPP) among Normal Control Adolescents (2003) (29)
- Plasma measures of B-endorphin-like immunoreactivity in depressives and other psychiatric subjects. (1982) (28)
- Depression and panic in patients with borderline personality disorder (1985) (27)
- Sleep deprivation in depressed adolescents and psychiatric controls. (1993) (26)
- Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia. (1991) (25)
- Facial EMG activity levels predict treatment outcome in depression (1984) (25)
- Extended antidepressant maintenance and discontinuation syndromes (1998) (23)
- Imipramine and tinnitus. (1987) (23)
- Multiplicity of depressive episodes: Phenomenological and neuroendocrine correlates (1990) (23)
- The dexamethasone suppression test in patients with alcoholism. (1983) (23)
- Treatment resistant depression : a roadmap for effective care (2011) (21)
- Monitoring of antidepressant response to ECT with polysomnographic recordings and the dexamethasone suppression test (1988) (21)
- Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. (1987) (21)
- The Michigan Peer-to-Peer Depression Awareness Program: School-Based Prevention to Address Depression Among Teens. (2018) (21)
- Selective effect of alcohol on cellular immune responses of lymphocytes from AIDS patients. (1994) (21)
- Electroconvulsive therapy in delusional and non-delusional depressive disorder. (1990) (20)
- CSF biochemical correlates of mixed affective states (1988) (20)
- Simultaneous panic and depressive disorders: Clinical and sleep EEG correlates (1986) (20)
- The effect of dexamethasone on sleep: preliminary results in eleven patients. (1984) (19)
- Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. (1983) (18)
- Application of Information Technology: The University of Michigan Honest Broker: A Web-based Service for Clinical and Translational Research and Practice (2009) (18)
- Seasonality in atypical depression (1992) (17)
- Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder (2020) (17)
- Benzodiazepines and catatonia (1990) (17)
- Development of the National Network of Depression Centers Mood Outcomes Program: A Multisite Platform for Measurement-Based Care. (2020) (17)
- Abnormal phosphoinositide turnover in schizophrenia (1991) (16)
- Severe Depressive Disorders (1994) (16)
- Long-term treatment for lifetime disorders? (1995) (15)
- Predictors of response to electroconvulsive therapy in major depressive disorder (1988) (15)
- Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy (1997) (14)
- Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations. (2013) (14)
- Public-academic partnerships: working together to meet the needs of Army National Guard soldiers: an academic-military partnership. (2010) (14)
- Workplace depression: personalize, partner, or pay the price. (2013) (14)
- Plasma dexamethasone levels in children given the dexamethasone suppression test (1989) (13)
- Treating depression and pain. (2009) (13)
- The National Network of Depression Centers: progress through partnership (2011) (13)
- Clinical predictors of 1-year outcome in schizophrenia. (1992) (12)
- The DST in borderline patients. (1983) (12)
- Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser. (1984) (12)
- Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. (1988) (12)
- Psychomotor monitoring: a promise being fulfilled? (1993) (12)
- Serial dexamethasone suppression tests in simultaneous panic and depressive disorders (1987) (12)
- Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial (2019) (12)
- The effect of amphetamine on plasma cortisol in patients with endogenous and non-endogenous depression (1981) (12)
- Techniques in Psychophysiology (1981) (11)
- Longitudinal studies: An essential component for complex psychiatric disorders (2016) (11)
- Application of biological markers in depression secondary to thyrotoxicosis. (1982) (11)
- Treatment of recurrent depression (2001) (11)
- Multiple depressive episodes and plasma postdexamethasone cortisol levels (1987) (11)
- The "Honest Broker" Method of Integrating Interdisciplinary research Data (2005) (10)
- Controversies in psychiatric education: a survey of residents' attitudes. (1975) (10)
- Workplace mental health programmes: the role of managers. (2017) (10)
- Rational Psychopharmacotherapy and the Right to Treatment (1975) (10)
- Serial monitoring of antidepressant response to electroconvulsive therapy with sleep EEG recordings and dexamethasone suppression tests (1985) (10)
- Sleep EEG, depression rating scales, and diagnosis. (1982) (10)
- Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion (2000) (10)
- Biological markers of melancholia and reclassification of depressive disorders. (1982) (9)
- Alcohol inhibits lipopolysaccharide-induced tumor necrosis factor alpha gene expression by peripheral blood mononuclear cells as measured by reverse transcriptase PCR in situ hybridization (1996) (9)
- The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks (1987) (9)
- Working Together to Meet the Needs of Army National Guard Soldiers: An Academic-Military Partnership (2010) (9)
- Polysomnographic studies in patients referred for ECT: pre-ECT studies. (1996) (9)
- Introduction. Part III. New agents for the treatment of depression. (1994) (9)
- The dexamethasone suppression test in repeated hospitalizations. (1983) (8)
- WORKING OUTSIDE THE HOME AND THE OCCURRENCE OF DEPRESSION IN MIDDLE-AGED WOMEN. (1965) (8)
- Variety of effects of trihexyphenidyl (THP) on schizophrenic and non-schizophrenic abusers. (1987) (8)
- Neutrotransmitter mechanism of neuroendocrine disturbance in depression (1978) (8)
- Serial dexamethasone suppression tests in affective disorders. (1980) (8)
- Menstrual cycle effects on the dexamethasone suppression test in major depression (1991) (7)
- Sleep-onset REM period in paranoid schizophrenia (1985) (7)
- Depression and pain (2008) (7)
- Chronic caffeine consumption and the dexamethasone suppression test in depression (1988) (7)
- Weight change with antidepressant treatment (1989) (7)
- Dexamethasone suppression test status and severity of depression (1988) (7)
- Functional Indices of Biological Disturbance (1983) (7)
- Mental Health in the Workplace: Strategies and Tools to Optimize Outcomes (2019) (7)
- The Tea Controversy in Colonial America. (1976) (7)
- Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe? (2020) (6)
- Recurrent depression: Its overwhelming burden. (2001) (6)
- Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression (2020) (6)
- Cholinergic mechanisms and REM sleep abnormalities in schizophrenia (1992) (6)
- Immunoregulatory effects of alcohol on lymphocyte responses to human immunodeficiency virus proteins. (1990) (6)
- Combinatorial PharmacogenomicTesting Improves Outcomes for Older Adults With Depression. (2020) (6)
- Suicidal Behavior and the DST: Lack of Association (1982) (6)
- beta-Endorphin/beta-lipotropin immunoreactivity in endogenous depression. Effect of dexamethasone. (1986) (6)
- Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression. (1985) (5)
- Standardization of the Dexamethasone Suppression Test for the Diagnosis of Melancholia1 (1981) (5)
- Comparison of Clinical, Research and Neuroendocrine Criteria (1980) (5)
- Relative Efficacy of Unilateral and Bilateral Electroconvulsive Therapy in Melancholia. (1988) (5)
- Serotonin: how much we have learned! So much to discover... (1998) (5)
- Sleep Electroencephalographic Studies After ECT: Age and Clinical Response. (1994) (5)
- The next 50 years: a new vision of "Community of Mental Health". (2013) (4)
- Child psychiatry education for general residents. (1979) (4)
- Healthy Minds at Work: Challenges and Strategies for Businesses (2019) (4)
- Selective inhibition by alcohol and cortisol of natural killer cell activity of lymphocytes from cord blood (1994) (4)
- Meige's syndrome or tardive dyskinesia? (1985) (3)
- Plasma postdexamethasone cortisol levels in schizoaffective disorder (1988) (3)
- Neuroendocrine diagnostic criteria for depression [proceedings]. (1980) (3)
- Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression. (2021) (3)
- Cholinergic mechanisms in schizophrenia: Relationship to sleep-EEG abnormalities and positive/ negative symptoms (1993) (3)
- Cholinergic Syndrome following Anticholinergic Withdrawal in a Schizophrenic Patient Abusing Marijuana (1989) (3)
- Clinical Case Conference (2005) (2)
- Annual meeting theme for 1992: Developmental neurobiology and clinical course (1991) (2)
- Mania induced by anti-depressant withdrawal (1986) (2)
- Caffeine and benzodiazepine use. (1982) (2)
- Clinical psychiatry conference: biological and family indicators in depression. (1983) (2)
- Plasma dexamethasone levels in children given the dexamethasone suppression test (1989) (2)
- Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder (2021) (2)
- Interdiscimplinary differences on a general hospital psychiatry unit. (1979) (2)
- Electroencephalographic sleep abnormalities in schizophrenia: Relationship to positive/negative symptoms and ventricular size (1989) (2)
- Diagnosing and treating depression earlier and preventing recurrences: Still neglected after all these years (2004) (2)
- Dexamethasone suppression test in primary degenerative dementia. (1983) (2)
- Mania induced by antidepressant withdrawal. (1986) (2)
- Errors in Administration of the Dexamethasone Suppression Test-Reply (1984) (2)
- Tests of Psychomotor Function (1985) (1)
- THE DEXAMETHASONE SUPPRESSION TEST: AN ESTABLISHED BIOLOGICAL MARKER OF MELANCHOLIA (1982) (1)
- Safety of Using a Combinatorial Pharmacogenomic Test for Patients with Major Depressive Disorder in the GUIDED trial. (2021) (1)
- Sleep Electroencephalographic Studies After ECT. (1994) (1)
- FLUOXETINE VS. PHENELZINE IN ATYPICAL DEPRESSION (1992) (1)
- Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies. (2019) (1)
- Electroencephalographic sleep abnormalities in schizophrenia: Relationship to positive/negative symptoms and ventricular enlargement (1989) (1)
- The Michigan Peer-to-Peer Depression Awareness Campaign: School-Based Prevention to Reduce the Impact of Depression Among Adolescents (2019) (1)
- Electro-convulsive treatment (ECT) in refractory adolescent depression (1995) (1)
- Effects of clozapine on sleep-eeg measures in schizophrenia (1995) (1)
- 49 Combinatorial Pharmacogenomics to Guide Treatment Selection for Major Depressive Disorder: A Large, Blinded, Randomized Controlled Trial (2019) (1)
- Do long-term treatments alter lifetime course? Lessons learned, actions needed. (1998) (1)
- Dexamethasone suppression test. (1982) (1)
- Dr. Valenstein and Colleagues Reply (2006) (1)
- Reconstructing schizophrenia: Lessons from major mood disorders (2022) (1)
- COMBINATORIAL PHARMACOGENETIC TESTING IMPROVES RESPONSE AND REMISSION FOR PATIENTS OVER 65 WITH DEPRESSION WHO HAVE FAILED ONE MEDICATION TRIAL (2020) (1)
- Does antidepressant step therapy fuel the law of unintended consequences? (2010) (1)
- HYPOTHALAMIC - PITUITARY - ADRENAL MONITORING (1986) (1)
- Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression. (2022) (1)
- Predictors of Antidepressant Response to Sleep Deprivation in Depressed Adolescents (1994) (1)
- DST and Schizophrenic symptomatology (I: Reply) (1989) (1)
- Marijuana: Medical Papers 1839–1972. TOD H. MIKURIYA, M.D. (Ed.), MediComp Press, Oakland, California, 1973, 465 pp., with illus. (1974) (0)
- 150 HAM-D6 Outcomes in a Randomized, Controlled Trial Evaluating the Utility of Combinatorial Pharmacogenomics in Depression (2020) (0)
- Contents of the American Journal of Psychiatry (1994) (0)
- The Impact of Genetics on Psychiatric Nosology (2006) (0)
- CPNP 2019 Annual Meeting Poster Abstracts (2019) (0)
- NATURAL AND LYMPHOKINE‐ACTIVATED KILLER CELL ACTIVITIES IN DEPRESSION AND SCHIZOPHRENIA (1992) (0)
- Serial dexamethasone suppression tests in depressed treated only with electroconvulsive therapy 233 patients (2002) (0)
- Psychopathology and Psychopharmacology (1973) (0)
- S-67-2 Lessons form the mood disorders: Close but no cigar (1996) (0)
- Possible impact of weekly DSTs on thyroid function in patients with affective disorders. (1985) (0)
- Neuroendocrine diagnostic criteria for depression (1980) (0)
- Clinician-Researchers in Psychiatry (1987) (0)
- Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study. (2021) (0)
- Response (1991) (0)
- Measure of Burden (2013) (0)
- Effect of caffeine on sexual function (1975) (0)
- in Endogenous Depression Effect of Dexamethasone (2017) (0)
- Caffeinism in eating disordered patients (1989) (0)
- Depressive Disorders (2019) (0)
- Response to electroconvulsive therapy in psychotic versus non-psychotic depression (1989) (0)
- Marijuana: Medical Papers, 1839-1972 (1974) (0)
- Dr. Kronfol and Associates Reply (2006) (0)
- Depression on College Campuses Conference: Addressing an Evolving Crisis (2021) (0)
- The Harvard Guide to Modern Psychiatry (1978) (0)
- Psychopharmacology in the Practice of Medicine (1978) (0)
- Mental Health Issues When College Students Are Sent Home by COVID-19 (2020) (0)
- Developmental neurobiology and clinical course (1992) (0)
- Life Events and Depression in Children with Pervasive Developmental Disorders 1 (2005) (0)
- S-67-6 Effects of clozapine on sleep-EEG measures in schizophrenia (1996) (0)
- From the editors' desks (1996) (0)
- Carroll Rating Scale (CRS) 1981 (2004) (0)
- Relationship between DST findings and polysomnographic abnormalities in schizophrenia (1994) (0)
- Letter to the Editor (1987) (0)
- Clinical correlates of cholinergic hyperactivity in schizophrenia (1995) (0)
- Weight change and sleep continuity in major depressive disorder (1989) (0)
- Effects of anticholinergic modulation on polysomnographic abnormalities in schizophrenia (1994) (0)
- Michelle Riba, M.D., M.S., 131st President, 2004–2005 (2005) (0)
- Evidence for the need of long-term treatment of major depression (2007) (0)
- [No Title] (1981) (0)
- PAULA J. CLAYTON, MD (2021) (0)
- Possible dexamethasone influences on subsequent serial DST results. (1985) (0)
- Response (1989) (0)
- Possible cholinergic mechanism in reserpine and tardive dyskinesia. (1984) (0)
- Effect of Imipramine versus Desipramine on Body Weight in Major Depression (1990) (0)
- Criminal background checks for psychiatry? Michigan's mental health exceptionalism. (2008) (0)
- TREATMENT OF RESISTANT DEPRESSION WITH 5‐HT UPTAKE INHIBITORS (1992) (0)
- Effects of Clozapine on Polysomnography Measures in Schizophrenia (1996) (0)
- The dexamethasone suppression test as a research variable (1983) (0)
- A High-Performance Liquid-Chromatographic Methodfor Routine Simultaneous Determination of NicotineandCotininein Plasma (1988) (0)
- Sleep encephalographic studies in schizophrenic patients: Comparison of neuroleptic-naive and previously-medicated patients with healthy controls (1991) (0)
- DEPRESSION : Mind and Body Advances in the Understanding and Treatment of Depression and its Physical Symptoms Biological and Psychosocial Correlates of Perimenopausal Depression : Implications for Treatment (2007) (0)
- Positive and Negative Symptoms in Schizophrenia and the Dexa ~ ethas ~ ne Suppression Test (2002) (0)
- Dr. Greden Replies (1995) (0)
- The authors reply (1986) (0)
- American Journal of Psychiatry: Presidential address (2005) (0)
- NNDC Special Issue: Challenges of Mood Disorders Care. (2020) (0)
- Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer. (2021) (0)
- News & notes (1990) (0)
- Drs. Greden and Genero Reply (1986) (0)
- In Memory of Elizabeth Young (2009) (0)
- Covariance of positive and negative symptoms during treatment with typical neuroleptics and clozapine (1993) (0)
- 2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition. (2017) (0)
- Suppressive Effect of Alcohol on Normal Lymphocyte Proliferative Response to HIV Antigens (1991) (0)
- Albert Silverman, 1925–2002 (2002) (0)
- Neurotransmitter studies of neuroendocrine pathology in depression. (1980) (0)
- 379. Antidepressant maintenance medications: A critical review (1996) (0)
- S36COMBINATORIAL PHARMACOGENOMIC TESTING IMPROVES OUTCOMES FOR PATIENTS TAKING MEDICATIONS WITH GENE-DRUG INTERACTIONS IN A RANDOMIZED, CONTROLLED TRIAL (2019) (0)
- In memoriam Daniel X. Freedman (1993) (0)
- Menstrual Effects on Neuroendocrine Measures (2019) (0)
- Clinical outcomes in the biomarkers of ketamine (bio-k) study of open-label iv ketamine for non-psychotic depression or bipolar disorder (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John F. Greden?
John F. Greden is affiliated with the following schools:
